MEDICINOVA INC (MNOV): Nasdaq/NYSE listing notice — MediciNova receives two Nasdaq deficiency notices for board and audit committee independence

MEDICINOVA INC

Received Audit Committee Notice on June 15, 2023 due to committee having two independent members instead of three.
Received Independent Board Notice on June 22, 2023 for having only two independent directors out of five board seats.
Cure period: until the earlier of next annual meeting or June 13, 2024 (or Dec 11, 2023 if meeting before then).
Company plans to appoint an additional independent director; no immediate impact on stock listing or trading.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

MEDICINOVA INC received a nasdaq deficiency notice notice regarding audit committee (rules 5605(c)(2)(A), 5605(b)(1)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: audit committee
Rules: 5605(c)(2)(A), 5605(b)(1)

Exact text from the filing

June 15, 2023, MediciNova, Inc. (the “Company”) received a letter (the “Audit Committee Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, due to Jeff Himawan, Ph.D. not standing for re-election as a Class I director of the Company at the Company’s 2023 annual meeting of stockholders held on June 13, 2023 (the “Annual Meeting”), the Company was no longer in compliance with Nasdaq Listing Rule 5605(c)(2)(A) (the “Audit Committee Listing Rule”), which requires the Audit Committee (the “Audit Committee”) of the Board of Directors (the “Board”) of the Company to be co

View on SEC.gov

Browse all listing & compliance notices →

MEDICINOVA INC filing history →

Source: SEC EDGAR

accession 0001193125-23-172585

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.